We believe that genetically-modified primates will offer new insights into higher cognition research, and have the potential to contribute significantly to new therapeutic strategies for addressing currently intractable neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis, as well as mental disorders such as schizophrenia and autism spectrum disorders.